Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Technique Allows Noninvasive Tracking, Imaging of Stem Cells in the Brain

By LabMedica International staff writers
Posted on 05 Apr 2011
A new technique using quantum dot technology generated through nanotechnology is a promising new tool for monitoring the effects of stem cell therapies for stroke and other types of brain damage. More...


The study's findings were published in the April 2011 issue of the journal Neurosurgery, the journal of the Congress of Neurological Surgeons. The researchers reported the successful use of near-infrared fluorescence labeling to track the behavior of injected stem cells in brain-injured rats. "The results open up new opportunities to develop noninvasive near-infrared fluorescence imaging...to track bone marrow stem cells transplanted into the human brain,” wrote Dr. Taku Sugiyama and colleagues of Hokkaido University Graduate School of Medicine (Sapporo, Japan).

The researchers utilized bone marrow stem cells to treat induced brain injuries, similar to stroke, in rats. Before injection, the stem cells were labeled with quantum dots, a biocompatible, fluorescent semiconductor created using nanotechnology.

Other fluorescence techniques used to label stem cells have an important limitation their comparatively short wavelengths do not easily penetrate through bone and skin. The quantum dots emit near infrared light, with much longer wavelengths that can easily penetrate tissues. This allowed the researchers to monitor the behavior of stem cells within the brain after transplantation using a computer-assisted, three-dimensional (3D) imaging system.

Using this technology, Dr. Sugiyama and colleagues were able to detect near-infrared fluorescence from the stem cells as they moved to and incorporated themselves into the area around the injured area of the brain. Reflecting the stem cells' behavior, the fluorescence increased gradually, peaking at four weeks after injection. The fluorescence remained detectable for up to eight weeks. The results were validated by direct examination of the brains.

Stem cell transplantation is a potentially beneficial treatment for stroke and other central nervous system disorders. The use of stem cells developed from the patient's own bone marrow is a particularly promising approach. For example, a study in the March 2011 issue of the journal Neurosurgery reported that bone marrow stem cell transplantation was a "logistically feasible and safe” approach to treatment of severe traumatic brain injury in children.

However, some sort of imaging system is needed to track the activity of stem cells as they travel to the injured area and develop into new brain cells. "Such techniques would be crucial to validate the therapeutic benefits of bone marrow stem cell transplantation for central nervous system disorders,” Dr. Sugiyama and coauthors wrote in their article.

Near-infrared fluorescence labeling using quantum dots appears to provide a noninvasive technique for monitoring the effects of stem cell transplantation in the rat brain. Additional studies will be needed to see if similar techniques can be developed and used in humans, according to the researchers. If so, this technology would be an important part of experimental stem cell therapies to enhance functional recovery of the brain after stroke or other types of injury.

Related Links:

Hokkaido University Graduate School of Medicine



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Specimen Radiography System
TrueView 200 Pro
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.